MedTrace Logo

Cast vs. Splints for Minimally Displaced Distal Radius Fractures in the Elderly

NCT02066857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2017-05-24

Study results available
· View outcomes & findings →

Summary

The purpose of this prospective randomized study is to add to the body of knowledge on the treatment of minimally displaced distal radius fractures in patients over 60 years of age. The investigators believe that treating minimally displaced distal radius fractures in people over 60 with a removable splint and early range of motion will provide greater patient satisfaction, fewer complications, and earlier functional returns to pre-injury for these patients compared to those treated with a short arm cast which immobilizes the limb for at least four weeks, and has been shown to lead to longer recovery and possible residual stiffness. The investigators hope to provide sufficient evidence in directing treatment that will give the most efficacious and the most satisfactory return of prior function to patients. Since distal radius fractures in the elderly are common because of poorer bone quality, the elderly proportion of the population is increasing, and controlling health costs is of current concern, answering the question of which treatment produces the best results for all these concerns is of increasing importance now.

Conditions

  • Radius; Fracture, Lower or Distal End

Interventions

DEVICE

Cast made of generic plaster or fiberglass cast material

Patients will randomly receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture.

DEVICE

Generic "off the shelf" removable splint

Patients will be randomized to receive a generic "off the shelf" removable splint for treatment of a non-displaced distal radius fracture.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Claudius Jarrett, M.D. · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066857 on ClinicalTrials.gov